# GlucoShield — Day 4 Final Mechanistic Digital Twin & Hybrid Forecasting Report
**Document ID:** `GLUCOSHIELD-RPT-DAY4-FINAL-001`  
**Timestamp:** 2026-08-28T15:33:00 Local Time  
**Author:** Lead Deep Learning & Physiological Systems Engineer  
**Hardware Platform:** NVIDIA GeForce RTX 4050 Laptop GPU (CUDA 12.6, PyTorch `2.13.0+cu126`)  
**Status:** **RESEARCH SUITE COMPLETED & CERTIFIED**  

---

## 1. Executive Summary & Benchmark Scorecard

The GlucoShield Day 4 research suite successfully developed, tested, and evaluated a **Physiology-Informed Digital Twin** and a **Differentiable Adaptive Hybrid Forecaster**.

Following locked validation selection, the final hybrid model was evaluated **once** on the permanently frozen, untouched **Test Set** ($N=4,113$ sequences from 17 patients: 2 T1DM + 15 T2DM).

### Final Benchmark Scorecard on Frozen Test Set:

| Model Architecture | Overall MAE (mg/dL) | Overall RMSE (mg/dL) | Clarke Zone A (%) | Clarke Zone B (%) | Clarke Zone A+B (%) | Clinical Status |
|---|:---:|:---:|:---:|:---:|:---:|:---:|
| **Day 2 Ridge Baseline** | $25.37$ | $35.80$ | $65.41\%$ | $27.90\%$ | $93.31\%$ | Baseline |
| **Day 3 Neural Forecaster V1 (GRU-128)** | $24.45$ | $34.90$ | $68.12\%$ | $27.16\%$ | $95.28\%$ | Strong Data-Driven |
| **Standalone Calibrated ODE Digital Twin** | $38.92$ | $52.41$ | $54.20\%$ | $34.62\%$ | $88.82\%$ | First-Principles Mechanistic |
| **GlucoShield Gated Hybrid (Winner Seed 7)** | **$24.14$** | **$34.77$** | **$68.58$**% | **$26.77$**% | **$95.36\%$** | **STATE-OF-THE-ART WINNER** |

### Benchmark Gains:
* **Over Day 2 Ridge Baseline:** Improved MAE by **$+1.23\text{ mg/dL}$ ($+4.8\%$)** and RMSE by **$+1.03\text{ mg/dL}$ ($+2.9\%$)**.
* **Over Locked Neural V1:** Improved MAE by **$+0.31\text{ mg/dL}$** and RMSE by **$+0.13\text{ mg/dL}$**, with higher Clarke Zone A accuracy ($68.58\%$ vs $68.12\%$).

---

## 2. 20-Point Scientific & Physiology Unit Test Certification

The core physiology engine (`physiology/`) was subjected to a comprehensive 20-point scientific unit test suite on CUDA GPU:
* **Pass Rate:** **20 / 20 Tests Passed (100.0%)** in $60.39\text{s}$.
* **Verified Properties:**
  1. Analytical exponential decay RK4 convergence ($<10^{-4}$ error).
  2. Mass conservation and non-negativity across all 6 compartments.
  3. Monotonic dose-dependent insulin depression (2U $\rightarrow$ 5U $\rightarrow$ 10U).
  4. Postprandial glucose absorption kinetics (peak between 45m and 135m).
  5. Interstitial sensor lag modeling ($G_{\text{cgm}}$ lags behind plasma $G_p$).
  6. 24-hour basal stability without mathematical explosion.
  7. Strict causal separation and parameter bounds compliance.
  8. CPU vs. CUDA numerical parity ($<10^{-3}\text{ mg/dL}$ absolute difference).

---

## 3. Detailed Horizon-Wise Breakdown on Frozen Test Set

The hybrid engine dynamically modulates between fast neural pattern recognition at short horizons ($k=1 \dots 4$) and first-principles metabolic clearance at extended horizons ($k=8 \dots 20$):

| Horizon | Future Time | Standalone ODE RMSE (mg/dL) | Hybrid Final RMSE (mg/dL) | Hybrid Final MAE (mg/dL) | Clarke Zone A+B (%) |
|---|:---:|:---:|:---:|:---:|:---:|
| **$k = 1$** | **+15 min** | $12.23$ | **$8.93$** | $5.72$ | **$99.39\%$** |
| **$k = 2$** | **+30 min** | $25.52$ | **$16.16$** | $10.65$ | **$98.83\%$** |
| **$k = 3$** | **+45 min** | $36.87$ | **$21.45$** | $14.48$ | **$98.32\%$** |
| **$k = 4$** | **+1 Hour (60m)** | $45.21$ | **$25.60$** | $17.65$ | **$97.20\%$** |
| **$k = 8$** | **+2 Hours (120m)** | $56.74$ | **$35.46$** | $25.40$ | **$94.77\%$** |
| **$k = 12$** | **+3 Hours (180m)** | $57.53$ | **$38.51$** | $28.32$ | **$94.12\%$** |
| **$k = 16$** | **+4 Hours (240m)** | $57.31$ | **$39.70$** | $29.80$ | **$94.16\%$** |
| **$k = 20$** | **+5 Hours (300m)** | $57.16$ | **$41.89$** | $31.85$ | **$93.70\%$** |

---

## 4. Subgroup & Macro-Patient Evaluation

| Subgroup / Cohort | Sample Size | Hybrid MAE (mg/dL) | Hybrid RMSE (mg/dL) | Clarke Zone A+B (%) |
|---|:---:|:---:|:---:|:---:|
| **Type 1 Diabetes (T1DM)** | $N = 2\text{ patients}$ ($507\text{ seqs}$) | $26.94$ | $37.20$ | $89.38\%$ |
| **Type 2 Diabetes (T2DM)** | $N = 15\text{ patients}$ ($3,606\text{ seqs}$) | $23.75$ | $34.42$ | $96.20\%$ |
| **Macro-Patient Average** | $N = 17\text{ patients}$ | $24.18 \pm 7.42$ | $34.27 \pm 9.75$ | $95.12 \pm 3.10\%$ |

---

## 5. Five Acute Risk Heads Evaluation on Test Set

| Clinical Event Head | Prediction Horizon | Threshold | Sensitivity / Recall (%) | Specificity (%) | Precision (%) | F1 Score (%) | AUPRC | AUROC | Brier Score |
|---|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|:---:|
| `hypo_1h` | Next 1 Hour | $<70\text{ mg/dL}$ | **$80.3\%$** | **$97.2\%$** | $61.7\%$ | $69.8\%$ | **$0.7796$** | **$0.9694$** | $0.0210$ |
| `hypo_2h` | Next 2 Hours | $<70\text{ mg/dL}$ | **$70.7\%$** | **$96.5\%$** | $60.9\%$ | $65.4\%$ | **$0.7206$** | **$0.9434$** | $0.0381$ |
| `hypo_4h` | Next 4 Hours | $<70\text{ mg/dL}$ | **$65.1\%$** | **$94.2\%$** | $56.4\%$ | $60.5\%$ | **$0.6598$** | **$0.9003$** | $0.0637$ |
| `hyper_2h` | Next 2 Hours | $>180\text{ mg/dL}$ | **$78.7\%$** | **$92.5\%$** | **$83.3\%$** | **$80.9\%$** | **$0.9100$** | **$0.9407$** | $0.0895$ |
| `hyper_4h` | Next 4 Hours | $>180\text{ mg/dL}$ | **$78.7\%$** | **$86.9\%$** | **$81.7\%$** | **$80.2\%$** | **$0.9081$** | **$0.9217$** | $0.1189$ |

---

## 6. Counterfactual What-If Clinical Case Studies

> **IMPORTANT CLINICAL RESEARCH DISCLAIMER:**  
> All simulated counterfactuals are generated using in-silico mathematical models for research purposes only. They do NOT constitute medical advice.

### Scenario 1: Meal Carbohydrate Load Variation (Standard 4U Bolus)
* **30g Meal:** Peak $= 138.4\text{ mg/dL}$ | Nadir $= 102.1\text{ mg/dL}$ | $\text{TIR} = 100.0\%$
* **60g Meal:** Peak $= 174.2\text{ mg/dL}$ | Nadir $= 108.5\text{ mg/dL}$ | $\text{TIR} = 100.0\%$
* **90g Meal:** Peak $= 208.7\text{ mg/dL}$ | Nadir $= 114.2\text{ mg/dL}$ | $\text{TIR} = 85.0\%$ (Postprandial Hyperglycemia)

### Scenario 2: Meal Timing Shift (Immediate vs. 30-min Delayed Meal)
* **Immediate Meal ($t=0$):** Peak $= 174.2\text{ mg/dL}$ | Nadir $= 108.5\text{ mg/dL}$
* **Delayed Meal ($t=30\text{min}$):** Initial insulin drop to Nadir $= 94.2\text{ mg/dL}$ before delayed meal absorption raises peak to $162.8\text{ mg/dL}$.

### Scenario 3: Bolus Timing Optimization (60g Meal, 4U Bolus)
* **Pre-Bolus 15 min:** Peak $= 158.4\text{ mg/dL}$ (Tightly controlled postprandial excursion)
* **At-Meal Bolus:** Peak $= 174.2\text{ mg/dL}$
* **Post-Bolus 15 min:** Peak $= 192.6\text{ mg/dL}$ (Higher glycemic spike due to delayed insulin onset)

### Scenario 4: Bolus Dose Scaling (60g Meal)
* **2U Bolus:** Peak $= 198.5\text{ mg/dL}$ | Nadir $= 132.1\text{ mg/dL}$
* **4U Bolus:** Peak $= 174.2\text{ mg/dL}$ | Nadir $= 108.5\text{ mg/dL}$
* **6U Bolus:** Peak $= 152.0\text{ mg/dL}$ | Nadir $= 86.4\text{ mg/dL}$
* **8U Bolus:** Peak $= 131.2\text{ mg/dL}$ | Nadir $= 64.8\text{ mg/dL}$ (Triggers Hypoglycemia Warning!)

### Scenario 5: Acute Hypoglycemia Rescue Carbohydrate Simulation
* **Crash State:** Initial Glucose $= 85\text{ mg/dL}$, Active $\text{IOB} = 4.5\text{ U}$.
* **Unmitigated Trajectory:** Nadir collapses to **$48.2\text{ mg/dL}$** (Severe Stage 2 Hypoglycemia at $t+45\text{min}$).
* **With 15g Fast-Acting Carbs ($t+30\text{min}$):** Nadir rebounds to **$72.6\text{ mg/dL}$** (**$+24.4\text{ mg/dL}$ protective rescue gain**, successfully averting severe shock).

### Scenario 6: Hyperglycemia Correction Bolus
* **Hyperglycemic State:** Initial Glucose $= 240\text{ mg/dL}$, $\text{IOB} = 0.2\text{ U}$.
* **No Correction:** Glucose remains elevated at $218.4\text{ mg/dL}$ after 5 hours.
* **With 2.0U Correction Bolus:** Glucose safely declines to $136.2\text{ mg/dL}$ (**$-82.2\text{ mg/dL}$ therapeutic reduction** back into euglycemic target range).

---

## 7. What the Digital Twin Adds Beyond Pure Deep Learning

While standalone ODE models have higher overall RMSE than pure GRUs on observational telemetry, the Digital Twin adds critical scientific capabilities that neural models cannot provide alone:
1. **Explainable Physiological States:** Internal tracking of unobserved states ($I_p$ plasma insulin, $X$ interstitial insulin action, $S_1/S_2$ gut carbohydrate transit).
2. **True Counterfactual Simulation:** Answering "What if I take 2U less insulin?" without requiring real-world clinical danger.
3. **Physical Conservation Bounds:** Bounding long-term trajectory divergence to realistic physiological clearance ranges.
4. **Transparent Personalization:** Mapping clinical biomarkers (HbA1c, BMI, C-Peptide) directly to patient-specific parameters ($S_I, V_G, k_a$).

---

## 8. Saved Artifacts Manifest

| Artifact File | Description | Location |
|---|---|---|
| `glucoshield_hybrid_best.pt` | Locked winning Hybrid model weights (Seed 7) | `D:\ML PROJECT\models\` |
| `glucoshield_hybrid_seed*.pt` | Checkpoints for Seeds 42, 123, 7 | `D:\ML PROJECT\models\` |
| `preds_hybrid_test.npy` | Array of hybrid trajectory predictions on Test set $(4113, 20)$ | `D:\ML PROJECT\results\digital_twin\` |
| `preds_ode_standalone_test.npy` | Array of standalone ODE predictions on Test set $(4113, 20)$ | `D:\ML PROJECT\results\digital_twin\` |
| `probs_risk_hybrid_test.npy` | Array of risk head probabilities on Test set $(4113, 5)$ | `D:\ML PROJECT\results\digital_twin\` |
| `digital_twin_experiment_summary.json` | Comprehensive machine-readable experimental summary | `D:\ML PROJECT\results\digital_twin\` |
| `digital_twin_training_progress.csv` | Benchmarking progress log table | `D:\ML PROJECT\results\digital_twin\` |

---
*Certified and locked for Day 4 milestone completion.*
